Want to join the conversation?
Biotechnology company $MNTA said the U.S. Court of Appeals for the Federal Circuit (CAFC) vacated the Massachusetts district court's summary judgment in favor of $AMPH to the extent it was based on the scope of the safe harbor provision of 271(e)(1), a research exemption which allows generic manufacturers to prepare generic drugs in advance.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?